EverSource Wealth Advisors’s Lyell Immunopharma LYEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.64K Buy
+167
New +$2.22K ﹤0.01% 3819
2025
Q3
– Sell
-1
Closed -$9 – 4416
2025
Q2
$9 Sell
1
-4
-80% -$36 ﹤0.01% 4232
2025
Q1
$57 Buy
+5
New +$61 ﹤0.01% 3887
2023
Q3
– Sell
-19
Closed -$1.23K – 2595
2023
Q2
$1.23K Buy
+19
New +$1.05K ﹤0.01% 2154

Other funds holding LYEL

EverSource Wealth Advisors's LYEL Position: Q3 2026 in Review

EverSource Wealth Advisors opened a new position in Lyell Immunopharma (LYEL) in Q3 2026: 167 shares worth $1.64K. The stake represents ﹤0.01% of the portfolio and ranks #3819 among its holdings. This is a return to the name: EverSource Wealth Advisors previously reported a position in LYEL as recently as Q2 2025.

EverSource Wealth Advisors first reported a position in LYEL in Q2 2023 and has held it in 4 quarters since. 105 funds tracked by Wall St. Rank hold LYEL as of Q3 2026.

  • EverSource Wealth Advisors held 167 shares of Lyell Immunopharma worth $1.64K as of Q3 2026.
  • Lyell Immunopharma was a new EverSource Wealth Advisors position in Q3 2026.
  • Lyell Immunopharma made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q3 2026, its #3819 holding.
  • EverSource Wealth Advisors first reported a position in Lyell Immunopharma in Q2 2023 and has held it in 4 quarters since.
  • 105 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q3 2026.

Based on EverSource Wealth Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.